BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Auernhammer CJ, Göke B. Medical treatment of gastrinomas. Wien Klin Wochenschr 2007;119:609-15. [PMID: 17985097 DOI: 10.1007/s00508-007-0877-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R;  Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98-119. [PMID: 22261919 DOI: 10.1159/000335591] [Cited by in Crossref: 332] [Cited by in F6Publishing: 248] [Article Influence: 33.2] [Reference Citation Analysis]
2 van Os E, Schrama M, Kamphuis K, de Herder WW, Damen GM. Abdominal pain and liver lesions in Zollinger-Ellison syndrome. J Pediatr Gastroenterol Nutr 2012;54:435-7. [PMID: 21760542 DOI: 10.1097/MPG.0b013e31822c42d9] [Reference Citation Analysis]
3 Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Drugs 2019;79:21-42. [PMID: 30560479 DOI: 10.1007/s40265-018-1033-0] [Reference Citation Analysis]
4 Niederle B. Hypergastrinemia--diagnosis and treatment. Wien Klin Wochenschr 2007;119:561-3. [PMID: 17985087 DOI: 10.1007/s00508-007-0897-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Guarnotta V, Martini C, Davì MV, Pizza G, Colao A, Faggiano A; NIKE group. The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Endocrine. 2018;60:15-27. [PMID: 29019150 DOI: 10.1007/s12020-017-1420-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Drugs 2019;79:21-42. [PMID: 30560479 DOI: 10.1007/s40265-018-1033-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
7 Ito T, Igarashi H, Uehara H, Jensen RT. Pharmacotherapy of Zollinger-Ellison syndrome. Expert Opin Pharmacother 2013;14:307-21. [PMID: 23363383 DOI: 10.1517/14656566.2013.767332] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
8 Grobmyer SR, Hochwald SN. Reoperative Surgery for the Zollinger-Ellison Syndrome. Advances in Surgery 2010;44:327-46. [DOI: 10.1016/j.yasu.2010.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Massaro SA, Emre SH. Metastatic gastrinoma in a pediatric patient with Zollinger-Ellison syndrome.J Pediatr Hematol Oncol. 2014;36:e13-e15. [PMID: 23426004 DOI: 10.1097/MPH.0b013e318282dadf] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]